CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
4.91
1.41%
Market Trading Hours* (UTC) Opens on Friday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.04
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026207 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026207%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.003985 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003985%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 4.98
Open 4.97
1-Year Change -34.52%
Day's Range 4.85 - 5
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 29, 2024 4.98 0.04 0.81% 4.94 5.08 4.85
May 28, 2024 5.10 0.09 1.80% 5.01 5.12 4.84
May 24, 2024 4.98 -0.27 -5.14% 5.25 5.28 4.95
May 23, 2024 5.24 -0.14 -2.60% 5.38 5.48 5.15
May 22, 2024 5.43 0.08 1.50% 5.35 5.57 5.32
May 21, 2024 5.37 0.11 2.09% 5.26 5.45 5.26
May 20, 2024 5.38 -0.08 -1.47% 5.46 5.59 5.30
May 17, 2024 5.42 -0.02 -0.37% 5.44 5.47 5.28
May 16, 2024 5.47 -0.03 -0.55% 5.50 5.65 5.46
May 15, 2024 5.62 0.25 4.66% 5.37 5.64 5.37
May 14, 2024 5.31 -0.01 -0.19% 5.32 5.53 5.23
May 13, 2024 5.37 0.11 2.09% 5.26 5.51 5.24
May 10, 2024 5.22 0.01 0.19% 5.21 5.48 5.16
May 9, 2024 5.20 0.00 0.00% 5.20 5.26 5.00
May 8, 2024 5.18 0.09 1.77% 5.09 5.27 5.06
May 7, 2024 5.27 -0.02 -0.38% 5.29 5.34 5.16
May 6, 2024 5.30 -0.08 -1.49% 5.38 5.43 5.26
May 3, 2024 5.36 0.01 0.19% 5.35 5.63 5.30
May 2, 2024 5.30 0.04 0.76% 5.26 5.38 5.13
May 1, 2024 5.25 0.32 6.49% 4.93 5.46 4.85

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Alector, Inc. Company profile

About Alector Inc

Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a therapeutic approach for the treatment of neurodegeneration. The Company is engaged in developing therapies designed to counteract these pathologies by restoring healthy immune function to the brain. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration and immunology to identify immune system. The Company has advanced four product candidates, AL001, AL002, AL003, and AL101, into clinical development. Its first product candidate, AL001, is a humanized recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of frontotemporal dementia carrying a progranulin (FTD-GRN) patients. Its AL002 targets triggering receptor expressed on myeloid cells 2 (TREM2) to increase the functionality of TREM2 signaling and enhance microglia cell activation.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Alector Inc revenues increased from $21.1M to $207.1M. Net loss decreased 81% to $36.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects General and administrative - Balancing decrease of 19% to $35.7M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$2.45 to -$0.45.

Industry: Bio Therapeutic Drugs

131 Oyster Point Blvd., Suite 600
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

News

PCE Index Preview: Forecasts point to no change in headline or core inflation from a month earlier

The markets continue to look for signals of disinflation in the United States. The latest PCE Index data, the US Federal Reserve’s preferred inflation gauge, is released on May 31, 2024.

12:44, 29 May 2024

Gold and Silver recover from last week’s pullback but face resistance ahead of US PCE

Gold and Silver move higher after last week’s pullbacks but the precious metals are struggling with resistance ahead of the US PCE release.

15:46, 28 May 2024

Copper price slumps as traders take profits, where to next?

Copper price drops over 5% on Thursday as traders take profits following the FOMC meeting minutes.

16:17, 24 May 2024

Market analysis: EUR/GBP driven by diverging policy expectations

The EURGBP is driven by the question: which cuts first, the ECB or the BOE? Currently, swaps markets (chart below) imply that it will be the ECB (blue line).

13:46, 24 May 2024

UK CPI Preview: Will inflation return to 2% as the BoE predicts? And how will it affect GBP?

The latest round of inflation data will be released at 22 April at 7 am BST and investors are likely going to be paying close attention.

15:44, 21 May 2024

Reserve Bank of New Zealand Preview: RBNZ could become more dovish as inflation eases and growth softens

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, May 22, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

15:29, 21 May 2024

Nvidia Q1 Earnings Preview: Analysts forecast another blockbuster set of results

Nvidia (NVDA) reports its Q1 results after the closing bell on Wednesday, May 22nd. We preview what to expect from Nvidia’s earnings and analyse its stock's technicals.

14:57, 21 May 2024

People also watch

BTC/USD

68,355.30 Price
+1.330% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.53 Price
-0.670% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

18,510.30 Price
-0.930% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Oil - Crude

77.72 Price
-1.840% 1D Chg, %
Long position overnight fee 0.0061%
Short position overnight fee -0.0280%
Overnight fee time 21:00 (UTC)
Spread 0.030

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading